SAGES evidence-based guidelines for the laparoscopic resection of curable colon and rectal cancer

Zerey, Marc; Hawver, Lisa Martin; Awad, Ziad T.; Stefanidis, Dimitrios; Richardson, William; Fanelli, Robert D.

doi:10.1007/s00464-012-2592-x

Cited by 91 publications

(56 citation statements)

References 111 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Although fosfomycin was as effective as comparators in these RCTs, it is not included in the recommended regimens in relevant guidelines (260)(261)(262). Finally, in an RCT, fosfomycin was compared with cefuroxime for knee arthroplasty.…”

Section: Prophylaxismentioning

confidence: 99%

Fosfomycin

et al. 2016

View full text Add to dashboard Cite

SUMMARYThe treatment of bacterial infections suffers from two major problems: spread of multidrug-resistant (MDR) or extensively drug-resistant (XDR) pathogens and lack of development of new antibiotics active against such MDR and XDR bacteria. As a result, physicians have turned to older antibiotics, such as polymyxins, tetracyclines, and aminoglycosides. Lately, due to development of resistance to these agents, fosfomycin has gained attention, as it has remained active against both Gram-positive and Gram-negative MDR and XDR bacteria. New data of higher quality have become available, and several issues were clarified further. In this review, we summarize the available fosfomycin data regarding pharmacokinetic and pharmacodynamic properties, thein vitroactivity against susceptible and antibiotic-resistant bacteria, mechanisms of resistance and development of resistance during treatment, synergy and antagonism with other antibiotics, clinical effectiveness, and adverse events. Issues that need to be studied further are also discussed.

show abstract

Section: Prophylaxismentioning

confidence: 99%

Fosfomycin

et al. 2016

View full text Add to dashboard Cite

show abstract

“…For colorectal cancer, laparoscopic surgery began to be performed around 1992, and this surgery is now listed in the guidelines as a standard procedure 1) . In addition, for renal cancer, laparoscopic surgery began to be performed around 1990, and this surgery is considered to be the standard procedure for stage I renal cancer with 7 cm or shorter tumor diameter in the guidelines for urological laparoscopic surgery in 2008 2) .…”

Section: Discussionmentioning

confidence: 99%

Simultaneous Laparoscopic Colectomy and Nephrectomy for Synchronous Ascending Colon Cancer and Right Kidney Cancer: Report of a Case

Takahashi

Ichikawa

Honjo

et al. 2014

Juntendo Medical Journal

View full text Add to dashboard Cite

Laparoscopic surgery has been widely applied to various surgical procedure, becoming standard procedure for colorectal and kidney cancer. Here, we describe a case of simultaneous laparoscopic surgery for synchronous colorectal and kidney cancer. A 70-year-old female was diagnosed with a tumor in the right lower abdomen. An abdominal CT showed tumors in the ascending colon and the right kidney. A colonoscopy demonstrated ascending colon cancer, and the patient was diagnosed synchronous ascending colon and right kidney cancer. Laparoscopic surgery was performed in cooperation with urologists. A right hemicolectomy was performed first at a lithotomy position. A right radical nephrectomy was then performed after changing to the left lateral position. The operation time was 450 minutes, and the blood loss was 60 ml. Chylous ascites were confirmed, but conservatively improved after surgery. Although synchronous colorectal and kidney cancers have not been confirmed in many cases, it is estimated that such synchronous cancers will increase with the aging of society and development of improved diagnostic imaging techniques. Therefore, simultaneous laparoscopic surgery is a safe and minimally invasive procedure with detailed surgical planning and a sophisticated surgical technique, including ensured port setting and body positioning, in cooperation with urologists.

show abstract

“…Previous reports have demonstrated the safety and feasibility of SPS in colorectal cancer, but their inclusion criteria yielded highly selected patients (with early cancer or small tumors) (11,12). The EAES consensus and SAGES guidelines do not necessary recommend laparoscopic en bloc resection for locally advanced adherent colon cancers (5,6). However, our results with S-MVR for advanced primary colon cancer had high reliability in terms of oncological clearance, blood loss, operative time and a successful completion rate regarding the regional oncologic aspect.…”

Section: Discussionmentioning

confidence: 99%

“…According to the European Association of Endoscopic Surgery (EAES) consensus, potentially curative resection of colon cancer suspected of invading the abdominal wall or adjacent structures should be undertaken by open surgery (5). In the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) guidelines, as open approach is suggested if a laparoscopic en bloc resection cannot be performed adequately for locally advanced adherent colon tumors (6). Because of increased the experience with laparoscopic approach for locally advanced colon cancer, the opportunities for adopting laparoscopic surgery for advanced colon cancer invading or adhering to neighboring organs or structures are considered to be increasing.…”

Section: Introductionmentioning

confidence: 99%

Safety and feasibility of single‑port laparoscopic multivisceral resection for locally advanced left colon cancer

et al. 2018

View full text Add to dashboard Cite

Abstract. The aim of the present study was to evaluate the safety and feasibility of single-port laparoscopic multivisceral resection (S-MVR) for locally advanced left colon cancer. S-MVR is a challenging technique and to the best of our knowledge this is the first report of S-MVR for left colon cancer invading or adhering to neighboring organs. A retrospective review was conducted of patients who underwent laparoscopic multivisceral resection for locally advanced left colon cancer invading or adhering to neighboring organs from January 2008 to December 2014. Short-term and long-term outcomes were analyzed between groups of patients who underwent S-MVR and multi-port laparoscopic multivisceral resection (M-MVR) retrospectively. A total of 14 patients underwent S-MVR and 15 patients underwent M-MVR. There were no significant differences between groups in terms of operative factors and postoperative complications. The length of hospital stay was significantly shorter in the S-MVR group compared with the M-MVR group (P=0.048). Three-year overall survival was 61.9% in the S-MVR group (n=14). In patients with stage II (P=0.600) and III (P=0714) disease the three-year overall and disease-free survival was 81.8 and 58.3% in the S-MVR group and 80.0 and 70% in the M-MVR groups over a median follow-up of 34 months. In conclusion, S-MVR for locally advanced left colon cancer is safe and feasible in selected patients.

show abstract

SAGES evidence-based guidelines for the laparoscopic resection of curable colon and rectal cancer

Cited by 91 publications

References 111 publications

Fosfomycin

Fosfomycin

Simultaneous Laparoscopic Colectomy and Nephrectomy for Synchronous Ascending Colon Cancer and Right Kidney Cancer: Report of a Case

Safety and feasibility of single‑port laparoscopic multivisceral resection for locally advanced left colon cancer

Contact Info

Product

Resources

About